Prevalence of Dyslipidemia Among Antiretroviral-Naive HIV-Infected Individuals in China
- PMID: 26632908
- PMCID: PMC4674211
- DOI: 10.1097/MD.0000000000002201
Prevalence of Dyslipidemia Among Antiretroviral-Naive HIV-Infected Individuals in China
Abstract
Little is known about the epidemiological features of dyslipidemia among antiretroviral-naive HIV-infected individuals in China. We used a cross-sectional study design to estimate the prevalence of dyslipidemia in this population, and to identify risk factors associated with the presence of dyslipidemia. One thousand five hundred and eighteen antiretroviral-naive HIV-infected individuals and 347 HIV-negative subjects in China were enrolled during 2009 to 2010. Demographics and medical histories were recorded. After an overnight fast, serum samples were collected to measure lipid levels. Factors associated with the presence of dyslipidemia were analyzed by logistic regression. Mean total cholesterol (TC), low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL) levels were lower in HIV-positive than HIV-negative subjects, but mean triglyceride (TG) was higher in HIV-positive subjects. The overall prevalence of dyslipidemia in HIV-positive and HIV-negative groups did not differ (75.6% vs. 73.7%, P = 0.580). However, the prevalence of high TC (8.4% vs. 28.2%, P < 0.001) and high LDL (8.5% vs. 62.6%, P < 0.001) was lower in HIV-positive than HIV-negative subjects, and the prevalence of high TG (33.9% vs. 17.0%, P < 0.001) and low HDL (59.6% vs. 11.2%, P < 0.001) was higher in HIV-positive than HIV-negative subjects. Logistic analysis showed that HIV positivity was significantly associated with both an increased risk of high TG and low HDL and a decreased risk of high TC and high LDL. The mean levels of TC, of LDL and of HDL showed an increasing trend with increasing CD4 count in HIV-positive subjects. Multivariable logistic regression found that lower CD4 count was significantly associated with both an increased risk of high TG and low HDL and a decreased risk of high TC in HIV-positive subjects. Among antiretroviral-naive HIV-infected Chinese adults, there was a high prevalence of dyslipidemia characterized by high TG and low HDL, which was associated with lower CD4 counts. These data support the assessment of lipid profiles before and after initiation of antiretroviral therapy regardless of age.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Similar articles
-
Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.PLoS One. 2021 Apr 27;16(4):e0250328. doi: 10.1371/journal.pone.0250328. eCollection 2021. PLoS One. 2021. PMID: 33905435 Free PMC article.
-
The effects of ART on the dynamics of lipid profiles in Chinese Han HIV-infected patients: comparison between NRTI/NNRTI and NRTI/INSTI.Front Public Health. 2023 Apr 27;11:1161503. doi: 10.3389/fpubh.2023.1161503. eCollection 2023. Front Public Health. 2023. PMID: 37181701 Free PMC article.
-
Dyslipidemia in ART-Naive HIV-Infected Persons in Nigeria--Implications for Care.J Int Assoc Provid AIDS Care. 2015 Jul-Aug;14(4):355-9. doi: 10.1177/2325957414555227. Epub 2014 Oct 20. J Int Assoc Provid AIDS Care. 2015. PMID: 25331224
-
Dyslipidemia among HIV-infected patients in Ethiopia: a systematic review and meta-analysis.BMC Infect Dis. 2024 Jan 2;24(1):27. doi: 10.1186/s12879-023-08910-9. BMC Infect Dis. 2024. PMID: 38166636 Free PMC article.
-
Dyslipidemia among adult HIV patients on antiretroviral therapy and its association with age and body mass index in Ethiopia: A systematic review and meta-analysis.PLoS One. 2024 May 9;19(5):e0298525. doi: 10.1371/journal.pone.0298525. eCollection 2024. PLoS One. 2024. PMID: 38722964 Free PMC article.
Cited by
-
A Link Between Methylglyoxal and Heart Failure During HIV-1 Infection.Front Cardiovasc Med. 2021 Dec 14;8:792180. doi: 10.3389/fcvm.2021.792180. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34970611 Free PMC article.
-
Immunometabolic Reprogramming in Response to HIV Infection Is Not Fully Normalized by Suppressive Antiretroviral Therapy.Viruses. 2022 Jun 15;14(6):1313. doi: 10.3390/v14061313. Viruses. 2022. PMID: 35746785 Free PMC article.
-
Cardiovascular Disease and Cardiovascular Disease Risk in HIV-Positive Populations in the Asian Region.Open AIDS J. 2017 Aug 21;11:52-66. doi: 10.2174/1874613601711010052. eCollection 2017. Open AIDS J. 2017. PMID: 29302277 Free PMC article.
-
Metabolic Profile of People Living with HIV in a Treatment Hub in Manila, Philippines: A Pre- and Post-Antiretroviral Analysis.J ASEAN Fed Endocr Soc. 2022;37(1):53-61. doi: 10.15605/jafes.037.01.17. Epub 2022 Feb 18. J ASEAN Fed Endocr Soc. 2022. PMID: 35800599 Free PMC article. Review.
-
Prevalence of cardiovascular risk factors in a historical cohort of people living with human immunodeficiency virus during a 10-year period.SAGE Open Med. 2023 Apr 24;11:20503121231166647. doi: 10.1177/20503121231166647. eCollection 2023. SAGE Open Med. 2023. PMID: 37123385 Free PMC article.
References
-
- Zhang F, Dou Z, Ma Y, et al. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis 2011; 11:516–524. - PubMed
-
- Blanco F, San Román J, Vispo E, et al. Management of metabolic complications and cardiovascular risk in HIV-infected patients. AIDS Rev 2010; 12:231–241. - PubMed
-
- Hasse B, Ledergerber B, Furrer H, et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2011; 53:1130–1139. - PubMed
-
- Falutz J. Therapy insight: body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy. Nat Clin Pract Endocrinol Metab 2007; 3:651–661. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous